Related Experiment Video
Updated: Apr 16, 2026
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
Monitoring asthma in children
Mariëlle W Pijnenburg1, Eugenio Baraldi2, Paul L P Brand3
1Dept of Paediatrics/Paediatric Respiratory Medicine, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
Insights
Monitoring asthma in children requires ongoing assessment of symptoms, lung function, and inflammation. Current evidence for integrating these factors for optimal pediatric asthma monitoring is limited, highlighting a need for further research.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Practice Guidelines
Background:
- Effective asthma management in children aims for clinical control and reduced future risks.
- Ongoing monitoring is crucial for achieving optimal asthma control in pediatric patients.
- Current understanding of integrating diverse asthma components (symptoms, lung function, bronchial hyperresponsiveness, inflammation) for monitoring is limited.
Purpose of the Study:
- To describe current practices in monitoring childhood asthma.
- To provide an overview of the best available evidence for monitoring children with asthma.
- To identify gaps in evidence regarding pediatric asthma monitoring strategies.
Main Methods:
- Literature review conducted by 22 clinical and research experts.
- Consensus reached using a modified Delphi method and four Task Force meetings.
- Synthesis of available evidence on monitoring tools and strategies for pediatric asthma.
Main Results:
- Available monitoring tools include clinical assessments, lung function tests, bronchial responsiveness measures, and inflammatory markers.
- The statement summarizes how these tools may be applied in pediatric asthma management.
- Significant lack of evidence exists for many aspects of monitoring asthma in children.
Conclusions:
- Despite interest, substantial evidence gaps persist in monitoring children with asthma.
- Further research is needed to develop integrated and evidence-based monitoring strategies.
- Optimal monitoring requires consideration of management, comorbidities, and environmental factors.
Abstract:
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist in various combinations in different individuals, to date there is limited evidence on how to integrate these for optimal monitoring of children with asthma. The aims of this ERS Task Force were to describe the current practise and give an overview of the best available evidence on how to monitor children with asthma. 22 clinical and research experts reviewed the literature. A modified Delphi method and four Task Force meetings were used to reach a consensus. This statement summarises the literature on monitoring children with asthma. Available tools for monitoring children with asthma, such as clinical tools, lung function, bronchial responsiveness and inflammatory markers, are described as are the ways in which they may be used in children with asthma. Management-related issues, comorbidities and environmental factors are summarised. Despite considerable interest in monitoring asthma in children, for many aspects of monitoring asthma in children there is a substantial lack of evidence.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...